Aspire Biopharma Holdings, Inc. operates as a biopharmaceutical company that engages in developing and marketing a disruptive technology for drugs, nutraceuticals & supplements. The company was founded on February 2, 2025 and is headquartered in Estero, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Aspire Biopharma Holdings Inc. market cap is $6.03M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aspire Biopharma Holdings Inc. 52 week high is $35.01 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aspire Biopharma Holdings Inc. 52 week low is $1.14 as of November 22, 2026.
Aspire Biopharma Holdings Inc. stock price today is $1.27.
Aspire Biopharma Holdings Inc. stock price yesterday was $1.20.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Aspire Biopharma Holdings Inc.'s P/E ratio is -0.02.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Aspire Biopharma Holdings Inc. P/B ratio is -0.1296.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Aspire Biopharma Holdings Inc. 50-day moving average is $2.33.